Remodeling of the HDL in NIDDM: a fundamental role for cholesteryl ester transfer protein

被引:15
作者
Castle, CK
Kuiper, SL
Blake, WL
Paigen, B
Marotti, KR
Melchior, GW [1 ]
机构
[1] Pharmacia & Upjohn Inc, Kalamazoo, MI 49001 USA
[2] Jackson Lab, Bar Harbor, ME 04609 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 1998年 / 274卷 / 06期
关键词
free apolipoprotein A-I; pre-beta apolipoprotein A-I; high-density lipoprotein lipase; mouse plasma lipase; KKA(y) mouse; mouse model of non-insulin-dependent diabetes mellitus;
D O I
10.1152/ajpendo.1998.274.6.E1091
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
When the Ar gene is expressed in KK mice, the yellow offspring (KKA(y) mice) become obese, insulin resistant, hyperglycemic, and severely hypertriglyceridemic, yet they maintain extraordinarily high plasma high-density lipoprotein (HDL) levels. Mice lack the ability to redistribute neutral lipids among circulating lipoproteins, a process catalyzed in humans by cholesteryl ester transfer protein (CETP). To test the hypothesis that it is the absence of CETP that allows these hypertriglyceridemic mice to maintain high plasma HDL levels, simian CETP was expressed in the KKA(y) mouse. The KKA(y)-CETP mice retained the principal characteristics of KKA(y) mice except that their plasma HDL levels were reduced (from 159 +/- 25 to 25 +/- 6 mg/dl) and their free apolipoprotein A-I concentrations increased (from 7 +/- 3 to 22 +/- 6 mg/dl). These changes appeared to result from a CETP-induced enrichment of the HDL with triglyceride (from 6 +/- 2 to 60 +/- 18 mol of triglyceride/mol of HDL), an alteration that renders HDL susceptible to destruction by lipases. These data support the premise that CETP-mediated remodeling of the HDL is responsible for the low levels of that lipoprotein that accompany hypertriglyceridemic non-insulin-dependent diabetes mellitus.
引用
收藏
页码:E1091 / E1098
页数:8
相关论文
共 37 条
  • [1] AGELLON LB, 1991, J BIOL CHEM, V266, P10796
  • [2] 2-DIMENSIONAL ELECTROPHORESIS OF PLASMA-LIPOPROTEINS - RECOGNITION OF NEW APO-A-I-CONTAINING SUBPOPULATIONS
    ASZTALOS, BF
    SLOOP, CH
    WONG, L
    ROHEIM, PS
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1169 (03) : 291 - 300
  • [3] THE ROLE OF LIPID TRANSFER PROTEINS IN PLASMA-LIPOPROTEIN METABOLISM
    BARTER, PJ
    HOPKINS, GJ
    HA, YC
    [J]. AMERICAN HEART JOURNAL, 1987, 113 (02) : 538 - 542
  • [4] BELFRAGE P, 1969, J LIPID RES, V10, P341
  • [5] THE BHE RAT - AN ANIMAL-MODEL FOR THE STUDY OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    BERDANIER, CD
    [J]. FASEB JOURNAL, 1991, 5 (08) : 2139 - 2144
  • [6] BRUNZELL JD, 1990, DIABETES MELLITUS TH, P756
  • [7] LIPOPROTEIN PROFILE CHARACTERIZATION OF THE KKA(Y) MOUSE, A RODENT MODEL OF TYPE-II DIABETES, BEFORE AND AFTER TREATMENT WITH THE INSULIN-SENSITIZING AGENT PIOGLITAZONE
    CASTLE, CK
    COLCA, JR
    MELCHIOR, GW
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (02): : 302 - 309
  • [8] CASTLE CK, 1991, J LIPID RES, V32, P439
  • [9] EXPRESSION OF THE HUMAN APOLIPOPROTEIN-A-I GENE IN TRANSGENIC MICE ALTERS HIGH-DENSITY-LIPOPROTEIN (HDL) PARTICLE-SIZE DISTRIBUTION AND DIMINISHES SELECTIVE UPTAKE OF HDL CHOLESTERYL ESTERS
    CHAJEKSHAUL, T
    HAYEK, T
    WALSH, A
    BRESLOW, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) : 6731 - 6735
  • [10] Increased lipase inhibition in uremia: Identification of pre-beta-HDL as a major inhibitor in normal and uremic plasma
    Cheung, AK
    Parker, CJ
    Ren, KS
    Iverius, PH
    [J]. KIDNEY INTERNATIONAL, 1996, 49 (05) : 1360 - 1371